Vasculitis Clinical Trials

Find Vasculitis Clinical Trials Near You

The Role of Intestinal Fatty Acid Binding Protein in Predicting Gastrointestinal Involvement in Pediatric IgA Vasculitis

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

This prospective observational study aims to evaluate plasma intestinal fatty acid-binding protein (I-FABP) levels in children with IgA vasculitis and investigate their association with gastrointestinal involvement. Blood samples will be collected at diagnosis and during follow-up 2-4 weeks later. The study will assess the potential value of plasma I-FABP as a biomarker for gastrointestinal involvement in pediatric IgA vasculitis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 2
Maximum Age: 18
Healthy Volunteers: f
View:

• Diagnosis of IgA vasculitis (Henoch-Schönlein purpura) according to EULAR/PRINTO/PRES classification criteria.

• Age between 2 and 18 years.

• Availability for blood sample collection at diagnosis (baseline visit).

• Ability to attend a routine follow-up visit approximately 2-4 weeks after diagnosis.

• Parent or legal guardian able and willing to provide written informed consent.

Locations
Other Locations
Turkey
Bursa City Hospital
RECRUITING
Bursa
Contact Information
Primary
Nur Şeyma Zengin, MD
nszengin37@hotmail.com
+90 5064767328
Backup
Tuba Kurt, MD, Associate Professor
drtubakurt@hotmail.com
+90 553 064 1000
Time Frame
Start Date: 2026-05-15
Estimated Completion Date: 2027-05-15
Participants
Target number of participants: 100
Treatments
Pediatric IgA Vasculitis Patients With Gastrointestinal Involvement
Children with IgA vasculitis and gastrointestinal involvement.
Pediatric IgA Vasculitis Patients Without Gastrointestinal Involvement
Children with IgA vasculitis without gastrointestinal involvement.
Related Therapeutic Areas
Sponsors
Leads: Bursa City Hospital

This content was sourced from clinicaltrials.gov